Skip to main content

EDITORIAL article

Front. Cell Dev. Biol.
Sec. Cancer Cell Biology
Volume 12 - 2024 | doi: 10.3389/fcell.2024.1470518
This article is part of the Research Topic Catch Me If You Can: Cellular Plasticity in Tumor Progression and Drug Resistance. View all 7 articles

Editorial: Catch me if you can: cellular plasticity in tumor progression and drug resistance

Provisionally accepted
Gian Luca Rampioni Vinciguerra Gian Luca Rampioni Vinciguerra 1*Ilenia Segatto Ilenia Segatto 2*Julienne L. Carstens Julienne L. Carstens 3,4*Sara Lovisa Sara Lovisa 5,6*
  • 1 Department of Clinical and Molecular Medicine, Faculty of Medicine and Psychology, Sapienza University of Rome, Rome, Lazio, Italy
  • 2 Unit of Molecular Oncology, Aviano Oncology Reference Center (IRCCS), Aviano, Italy
  • 3 O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, United States
  • 4 Department of Medicine, Division of Hematology & Oncology, University of Alabama at Birmingham, Birmingham, United States
  • 5 Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy
  • 6 Department of Gastroenterology, IRCCS Humanitas Research Hospital, Rozzano, Italy, Rozzano, Italy

The final, formatted version of the article will be published soon.

    Keywords: Cellular plasticity, Epithelial- mesenchymal transition (EMT), Drug Resistance, Tumor micro environment, Metaplasia, Cell stress adaptation, tumor micro environment (TME), immune escape

    Received: 25 Jul 2024; Accepted: 07 Aug 2024.

    Copyright: © 2024 Rampioni Vinciguerra, Segatto, Carstens and Lovisa. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Gian Luca Rampioni Vinciguerra, Department of Clinical and Molecular Medicine, Faculty of Medicine and Psychology, Sapienza University of Rome, Rome, 00185, Lazio, Italy
    Ilenia Segatto, Unit of Molecular Oncology, Aviano Oncology Reference Center (IRCCS), Aviano, 2-33081, Italy
    Julienne L. Carstens, O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, United States
    Sara Lovisa, Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, 20090, Italy

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.